ATP2B3
protein-codingATPase plasma membrane Ca2+ transporting 3, the group of ATPases Ca2+ transporting|Cilia and flagella associated
Gene summary
The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 3. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
- SCAX1
- CLA2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~65.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010404
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010547
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010547
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0010547
Submitter: Genomics England PanelApp
Inheritance Pattern: XL
Disease ID:MONDO:0010547
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ATP2B3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001001344.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 46 | 10 | 60 | ||
| missense | 6 | 139 | 37 | 2 | 184 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 0 | 7 | 152 | 85 | 12 | 256 |
Highest pathogenic variant AF is 0.000014951955
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001001344.1 | 20 | MANE Select | |
| Ensembl | ENSP00000263519.4 | 20 | MANE Select | |
| RefSeq | NP_001375289.1 | 21 | Standard | |
| RefSeq | NP_001375290.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aldosterone synthesis and secretion - Homo sapiens (human)
- Adrenergic signaling in cardiomyocytes - Homo sapiens (human)
- Calcium signaling pathway - Homo sapiens (human)
- cAMP signaling pathway - Homo sapiens (human)
- Salivary secretion - Homo sapiens (human)
Biological Process
- cellular calcium ion homeostasis
- ion transmembrane transport
- regulation of cytosolic calcium ion concentration
- calcium ion transmembrane transport
- ATP hydrolysis coupled cation transmembrane transport
Molecular Function
- calcium-transporting ATPase activity
- protein binding
- calmodulin binding
- ATP binding
- calcium ion transmembrane transporter activity
Cellular Component
- Golgi apparatus
- plasma membrane
- integral component of plasma membrane
- presynapse
- glutamatergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000263519
- Coding exons
- 20
- Length
- 65264
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 4
- Defined
- 125743
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.75 | 405 | 593 | 0.683 | 0.0000555 | 7960 |
| Missense (PolyPhen) | 137 | 262.81 | 0.52129 | 3357 | ||
| Synonymous | -0.144 | 279 | 276 | 1.01 | 0.0000290 | 2481 |
| Loss of Function | 5.00 | 3 | 34.9 | 0.0861 | 0.00000251 | 568 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000072 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000050 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell.;
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- LoFtool
- 0.000758
- RVIS EVS
- -1.68
- RVIS percentile EVS
- 2.68
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |